We are live on ! Find out more
STJ

St Jude Medical
STJ

Delisted

STJ was delisted on the 4th of January, 2017.

618 hedge funds and large institutions have $16.9B invested in St Jude Medical in 2015 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 253 increasing their positions, 180 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more call options, than puts

Call options by funds: $87.4M | Put options by funds: $42.7M

41% more repeat investments, than reductions

Existing positions increased: 253 | Existing positions reduced: 180

24% more first-time investments, than exits

New positions opened: 67 | Existing positions closed: 54

2% more funds holding

Funds holding: 608618 (+10)

4% less capital invested

Capital invested by funds: $17.6B → $16.9B (-$659M)

43% less funds holding in top 10

Funds holding in top 10: 148 (-6)

Holders
618
Holders Change
+10
Holders Change %
+1.64%
% of All Funds
17.25%
Holding in Top 10
8
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-42.86%
% of All Funds
0.22%
New
67
Increased
253
Reduced
180
Closed
54
Calls
$87.4M
Puts
$42.7M
Net Calls
+$44.8M
Net Calls Change
-$29.5M
Name Holding Trade Value Shares
Change
Change in
Stake
MAM
126
Martingale Asset Management
Massachusetts
$14.5M +$12.1M +169,227 +280%
GT
127
Glenmede Trust
Pennsylvania
$13.6M +$3.16M +44,333 +26%
FQ
128
First Quadrant
California
$13.5M +$764K +10,700 +5%
DCM
129
Decatur Capital Management
Georgia
$13.1M -$371K -5,200 -2%
CAM
130
ClariVest Asset Management
California
$13M +$535K +7,500 +4%
Two Sigma Investments
131
Two Sigma Investments
New York
$12.8M -$19M -266,517 -57%
CS
132
Candriam SCA
Luxembourg
$12.8M +$2.95M +41,310 +26%
VOYA Investment Management
133
VOYA Investment Management
Georgia
$12.1M +$118K +1,659 +0.9%
RPAM
134
Rhenman & Partners Asset Management
Sweden
$12M +$7.64M +107,000 +129%
PFM
135
Parsec Financial Management
North Carolina
$11.9M +$62.4K +874 +0.5%
SCM
136
Suffolk Capital Management
New York
$11.5M -$1.23M -17,268 -9%
CIS
137
Capital International Sarl
California
$11.4M
BTW
138
Boston Trust Walden
Massachusetts
$11.3M -$867K -12,151 -6%
IGIM
139
I.G. Investment Management
Manitoba, Canada
$11.1M -$856K -12,000 -6%
UCFA
140
United Capital Financial Advisors
Texas
$11M +$206K +2,881 +2%
ZA
141
Zweig Advisers
Connecticut
$10.9M
Stifel Financial
142
Stifel Financial
Missouri
$10.8M +$576K +8,073 +5%
DekaBank Deutsche Girozentrale
143
DekaBank Deutsche Girozentrale
Germany
$10.6M -$88.2K -1,236 -0.7%
SCM
144
Sirios Capital Management
Massachusetts
$10.5M +$4.86M +68,053 +69%
Barclays
145
Barclays
United Kingdom
$10.4M -$1.74M -24,392 -13%
SIP
146
Stoneridge Investment Partners
Pennsylvania
$10.3M +$11.7M +164,045 New
TCM
147
Tekla Capital Management
Massachusetts
$10.2M
FAM
148
Fred Alger Management
New York
$10.1M +$724K +10,147 +7%
MLICM
149
Metropolitan Life Insurance Company (MetLife)
New York
$10.1M -$140K -1,958 -1%
Retirement Systems of Alabama
150
Retirement Systems of Alabama
Alabama
$10M -$125K -1,756 -1%

STJ Hedge Fund Activity: Q3 2015 in Review

618 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q3 2015, worth a combined $16.9B — down 3.8% from $17.6B a quarter earlier.

Buyers outnumbered sellers: 67 funds opened new STJ positions and 54 closed out — a net gain of 13 holders — while 253 added to existing stakes and 180 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $113M. The largest seller was Capital Research Global Investors, cutting an estimated $234M.

  • 618 institutional investors held St Jude Medical (STJ) as of Q3 2015, up from 608 in Q2 2015.
  • Funds reported $16.9B of St Jude Medical stock for Q3 2015, down 3.8% quarter-over-quarter.
  • 67 funds opened new St Jude Medical positions in Q3 2015 and 54 closed out, a net change of +13 holders.
  • The largest St Jude Medical buyer in Q3 2015 was Fidelity Investments, an estimated $113M added.
  • The largest St Jude Medical seller in Q3 2015 was Capital Research Global Investors, an estimated $234M sold.

Based on aggregated 13F filings for Q3 2015.